The Effectiveness of Osteopathic Manipulative Medicine in the Management of Headaches Associated With Post Concussion Syndrome
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04732338 |
|
Recruitment Status :
Completed
First Posted : February 1, 2021
Results First Posted : May 25, 2021
Last Update Posted : May 25, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Headache Post-Concussion Syndrome | Other: Osteopathic Manipulative Therapy | Early Phase 1 |
Evidence shows the effectiveness of Osteopathic Manipulative Treatment (OMT) for various headache types, with limited evidence of its use for headaches related to mild traumatic brain injury (MTBI). No studies were found regarding OMT for headaches in patients with post-concussion syndrome (PCS), defined as symptom persistence >3 months after MTBI.
Objective: To evaluate OMT for headaches in patients with PCS. Methods: A controlled pilot study was conducted of patients with PCS who presented to an outpatient interdisciplinary rehabilitation clinic. Twenty-six subjects with symptoms lasting >3 months were enrolled and were randomly assigned to a treatment group (n = 13) and a control group (n = 13). Primary outcome measures were 1) immediate change in headache scores with a visual analog scale (VAS) and 2) change in the 6-item Headache Impact Test (HIT-6) between baseline and follow-up visits. 10 control participants completed HIT-6 between baseline and follow-up visits but did not receive OMT and did not complete VAS. After OMT, immediate VAS changes in treatment group and the improvements in HIT-6 scores for both groups between baseline and follow-up were analyzed for statistical significance.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 26 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | The Effectiveness of Osteopathic Manipulative Medicine in the Management of Headaches Associated With Post Concussion Syndrome |
| Actual Study Start Date : | August 1, 2017 |
| Actual Primary Completion Date : | March 31, 2019 |
| Actual Study Completion Date : | February 11, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Study arm - Osteopathic Manipulative Therapy
Standard of care including physical therapy, occupational therapy and over the counter medication AND OMT as described below:
Assessment with Headache Impact Test (HIT-6) at baseline and follow-up visit and change in pain scores between baseline and post treatment. |
Other: Osteopathic Manipulative Therapy
Osteopathic Manipulative Therapy (OMT) is a non-pharmacological, noninvasive form of manual medicine. Osteopathic practitioners use a wide variety of therapeutic manual techniques to improve physiological function and help restore homeostasis in the body. There is a structural assessment is to identify possible abnormalities of tissue texture. Areas of asymmetry and misalignment of bony landmarks are also evaluated, along with the quality of motion, balance, and organization. These asymmetries, also known as somatic dysfunctions, are then treated by a variety of manual treatments, administered by osteopaths. |
|
No Intervention: Control - Standard of care
Standard of care including physical therapy, occupational therapy and over the counter medication.
|
- Immediate Change in Headache Scores With a Visual Analog Scale (VAS) [ Time Frame: Same day with treatment on visit 1 ]
Change in the headache scores, defined as the different pain pre and post treatment using the visual analog scale (VAS).
VAS is widely used to capture pain, the scale ranges from 0-10 with 0 (best outcome) being no pain and 10 being the worst pain possible (worst outcome).
- Change in the 6-item Headache Impact Test (HIT-6) Between Baseline and Follow-up Visit. [ Time Frame: 4 weeks post treatment (Follow-up visit 1) ]
HIT-6 was completed at baseline and competed to HIT-6 completed post treatment at follow up visit.
Headache Impact Test (HIT-6) is a measure of headache severity and provides information regarding the effect of headache on other domains related to functional participation. The HIT-6 has six questions and the range goes from 36 (best outcome) to a maximum score of 78 (worst outcome). Higher HIT-6 scores indicate increased headache severity and greater functional limitations.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- diagnosis of mild traumatic brain injury (MTBI),
- age 18 years or older
- injury occurring >3 months prior, and
- headache as a primary symptomatic concern.
Exclusion Criteria:
- history of moderate to severe traumatic brain injury (TBI),
- documented intracranial injury,
- chronic headache or migraine headache before the injury,
- treatment with a headache specialist at the time of injury, or receipt of IV infusion for medication for headache at the time of treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04732338
| United States, New Jersey | |
| Hackensack Meridian Health - JFK Medical Center | |
| Edison, New Jersey, United States, 08817 | |
| Principal Investigator: | Alphonsa Thomas, DO | HMH-JFK |
Documents provided by Hackensack Meridian Health:
| Responsible Party: | Hackensack Meridian Health |
| ClinicalTrials.gov Identifier: | NCT04732338 |
| Other Study ID Numbers: |
IRB00001814 |
| First Posted: | February 1, 2021 Key Record Dates |
| Results First Posted: | May 25, 2021 |
| Last Update Posted: | May 25, 2021 |
| Last Verified: | May 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Post-Concussion Syndrome Syndrome Headache Disease Pathologic Processes Pain Neurologic Manifestations |
Brain Concussion Head Injuries, Closed Craniocerebral Trauma Trauma, Nervous System Nervous System Diseases Wounds and Injuries Wounds, Nonpenetrating |

